(Q70191732)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040509%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Natural killer activity in patients with chronic hepatitis treated with OK432, interferon, adenine arabinoside and glycyrrhizin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040509%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

T Wada

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040509%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

T Arima

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040509%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

H Nagashima

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040509%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

publication date

1 June 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040509%20AND%20SRC:MED&resulttype=core&format=json

Gastroenterologia Japonica

9 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040509%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040509%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040509%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

312-321

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040509%20AND%20SRC:MED&resulttype=core&format=json

Cell-mediated immunity to HBcAg and HBsAg in patients with chronic hepatitis

9 October 2019

cites work

1 reference

12 December 2020

Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg positive chronic liver disease

1 reference

12 December 2020

Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with high familial incidences of cancer

1 reference

12 December 2020

Depressed natural killer cell activity in patients with hepatocellular carcinoma. In vitro effects of interferon and levamisole

1 reference

12 December 2020

Diminished active T rosette levels and increased spontaneous B lymphocyte blastogenesis in hepatitis B virus positive chronic active hepatitis.

1 reference

12 December 2020

In situ ultrastructural detection and quantitation of liver mononuclear phagocytes in contact with hepatocytes in chronic type B hepatitis

1 reference

12 December 2020

Reversible induction of natural killer cell activity in cloned murine cytotoxic T lymphocytes

1 reference

12 December 2020

Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production

1 reference

12 December 2020

K-cell-mediated antibody-dependent cellular cytotoxicity in chronic active liver disease

1 reference

12 December 2020

Pit cell-hepatocyte contact in autoimmune hepatitis

1 reference

12 December 2020

Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus infection.

1 reference

12 December 2020

Cellular immunity and hepatitis-associated, Australia antigen liver disease

1 reference

12 December 2020

Lymphocyte subpopulations at the site of "piecemeal" necrosis in end stage chronic liver diseases and rejecting liver allografts in cyclosporine-treated patients

1 reference

12 December 2020

Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

1 reference

12 December 2020

Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g

1 reference

12 December 2020

HBeAg/Anti-HBe System and Cell-Mediated Immunity in Patients with HBsAg-Positive Chronic Active Hepatitis

1 reference

12 December 2020

Enhanced in vitro cell-mediated cytotoxicity in chronic hepatitis B virus infection: absence of specificity for virus-expressed antigen on target cell membranes

1 reference

12 December 2020

Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life

1 reference

12 December 2020

Spontaneous cell-mediated (SCMC) and antibody-dependent cellular cytotoxicity (ADCC) in patients with acute and chronic active hepatitis

1 reference

12 December 2020

Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B

1 reference

12 December 2020

Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor

1 reference

12 December 2020

Effect of liver disease on pharmacokinetics and toxicity of 9-beta-D-arabinofuranosyladenine-5-phosphate

1 reference

12 December 2020

Hepatitis B virus and HLA antigen display in the liver during chronic hepatitis B virus infection

1 reference

12 December 2020

Analysis with OKT monoclonal antibodies of T-lymphocyte subsets present in blood and liver of patients with chronic active hepatitis

1 reference

12 December 2020

Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome

1 reference

12 December 2020

Natural killer activity of human blood lymphocytes

1 reference

12 December 2020

Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal, West Africa

1 reference

12 December 2020

Fatal complications of virus hepatitis in two patients with agammaglobulinemia

1 reference

12 December 2020

In vitro augmentation of natural killing activity by OK-432

1 reference

12 December 2020

Natural killer cells in resistance to virus-infected cells

1 reference

12 December 2020

Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis

1 reference

12 December 2020

Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2

1 reference

12 December 2020

Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon

1 reference

12 December 2020

Core antigen-specific immunoglobulin G bound to the liver cell membrane in chronic hepatitis B

1 reference

12 December 2020

A species of human alpha interferon that lacks the ability to boost human natural killer activity

1 reference

12 December 2020

Large granular lymphocytes provide an accessory function in the in vitro development of influenza A virus-specific cytotoxic T cells.

1 reference

12 December 2020

T lymphocyte sensitization to HBcAg and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease.

1 reference

12 December 2020

Involvement of the cytotoxic/suppressor T-cell subset in liver tissue injury of patients with acute and chronic liver diseases

1 reference

12 December 2020

The Mechanism of Action of Inhibitors of DNA Synthesis

1 reference

12 December 2020

Response of resting human peripheral blood natural killer cells to interleukin 2.

1 reference

12 December 2020

Assay of augmentation of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity by interferon

1 reference

12 December 2020

The delineation of antigen receptors on human T lymphocytes

1 reference

12 December 2020

Cytotoxicity by NK-like cells from hepatitis B-immune patients to a human hepatoma cell line secreting HBsAg

1 reference

12 December 2020

Impaired T cell function and decreased natural killer activity in patients with liver cirrhosis and their significance in the development of hepatocellular carcinoma

1 reference

12 December 2020

Immune Mechanisms and the Action of Interferon in Chronic Hepatitis B Virus Infection

1 reference

12 December 2020

Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells

1 reference

12 December 2020

Decreased natural killer activity in patients with liver cirrhosis

1 reference

12 December 2020

Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes

1 reference

12 December 2020

In situ characterization by monoclonal antibodies of the mononuclear cell infiltrate in chronic active hepatitis

1 reference

12 December 2020

Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis

1 reference

12 December 2020

Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens

1 reference

12 December 2020

In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432

1 reference

12 December 2020

Rapid progression of chronic active type B hepatitis in a patient with hypogammaglobulinemia

1 reference

12 December 2020

A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by antibody OKT8

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02774257

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040509%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference